• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1980 年至 2017 年中国的中风流行病学和中风政策:系统评价和荟萃分析。

Stroke epidemiology and stroke policies in China from 1980 to 2017: A systematic review and meta-analysis.

机构信息

Asia Health Policy Program, Stanford University, Stanford, CA, USA.

First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Int J Stroke. 2020 Jan;15(1):18-28. doi: 10.1177/1747493019873562. Epub 2019 Sep 22.

DOI:10.1177/1747493019873562
PMID:31543073
Abstract

BACKGROUND

Stroke is the leading cause of death and years of life lost in China, and this problem is growing because stroke risk factors such as hypertension and hypercholesteremia have been on the rise as China experiences the demographic transition. The Chinese government has created public health initiatives in the form of guidelines, policies and programs to combat this problem, but the dissemination and effectiveness of these policies are not well known.

AIMS

The aim of this study was to determine trends in stroke incidence, prevalence, and stroke-related mortality in China and to report these trends in the context of stroke initiatives that have been enacted by the Chinese government.

SUMMARY OF REVIEW

We systematically reviewed articles on stroke rates and stroke initiatives from 1980 to 2017. A meta-regression including 11 studies showed that stroke incidence remained stable at 128.3 per 100,000 per year from 1980 to 2005 and has increased by 21.3 per 100,000 per year since then to 298.7 per 100,000 per year in 2013. A meta-regression including seven studies demonstrated a gradual decline in stroke-related mortality by 6.5 per 100,000 per year since 1980 (a decline from 369.2 in 1980 to 154.7 per 100,000 per year in 2013). Average stroke prevalence was 898.4 per 100,000 over the entire time-period. Limitations included heterogeneity between the studies. We identified 12 stroke initiatives, the first of which was enacted in 2006.

CONCLUSIONS

Despite numerous public health initiatives aimed at combating stroke that started in 2006, stroke incidence in China has increased over the last decade, likely as a result of aging and urbanization of the Chinese population.

摘要

背景

在中国,中风是导致死亡和丧失生命年数的主要原因,由于高血压和高胆固醇血症等中风危险因素的增加,中国正经历人口转型,这一问题日益严重。中国政府已经制定了公共卫生计划,以指南、政策和项目的形式来应对这一问题,但这些政策的传播和有效性并不为人所知。

目的

本研究旨在确定中国中风发病率、患病率和中风相关死亡率的趋势,并在报告这些趋势时结合中国政府实施的中风计划。

综述摘要

我们系统地回顾了 1980 年至 2017 年有关中风发病率和中风计划的文章。包括 11 项研究的荟萃回归显示,1980 年至 2005 年中风发病率每年稳定在 128.3/10 万人,此后每年增加 21.3/10 万人,至 2013 年达到 298.7/10 万人。包括 7 项研究的荟萃回归表明,自 1980 年以来,中风相关死亡率每年逐渐下降 6.5/10 万人(从 1980 年的 369.2/10 万人下降到 2013 年的 154.7/10 万人)。整个时期的平均中风患病率为 898.4/10 万人。研究之间存在异质性。我们确定了 12 项中风计划,其中第一项于 2006 年实施。

结论

尽管 2006 年开始实施了多项旨在防治中风的公共卫生计划,但中国的中风发病率在过去十年中有所增加,这可能是由于中国人口的老龄化和城市化。

相似文献

1
Stroke epidemiology and stroke policies in China from 1980 to 2017: A systematic review and meta-analysis.1980 年至 2017 年中国的中风流行病学和中风政策:系统评价和荟萃分析。
Int J Stroke. 2020 Jan;15(1):18-28. doi: 10.1177/1747493019873562. Epub 2019 Sep 22.
2
Pediatric stroke among Hong Kong Chinese subjects.香港华裔儿童的中风情况。
Pediatrics. 2004 Aug;114(2):e206-12. doi: 10.1542/peds.114.2.e206.
3
Increasing burden of stroke in China: A systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality.中国卒中负担日益加重:一项基于患病率、发病率、死亡率和病死率的系统评价和荟萃分析。
Int J Stroke. 2023 Mar;18(3):259-267. doi: 10.1177/17474930221135983. Epub 2022 Nov 16.
4
Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013.2002年至2013年中国卒中流行病学及其危险因素的快速转变。
Neurology. 2017 Jul 4;89(1):53-61. doi: 10.1212/WNL.0000000000004056. Epub 2017 May 31.
5
Secular trends of stroke incidence and mortality in China, 1990 to 2016: The Global Burden of Disease Study 2016.中国 1990 至 2016 年的卒中发病率和死亡率的变化趋势:2016 年全球疾病负担研究。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104959. doi: 10.1016/j.jstrokecerebrovasdis.2020.104959. Epub 2020 Jun 2.
6
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.美国疾病控制与预防中心国家健康报告:2005 - 2013年美国发病和死亡的主要原因以及相关行为风险和保护因素
MMWR Suppl. 2014 Oct 31;63(4):3-27.
7
Trends in Outcomes of Patients With Ischemic Stroke Treated Between 2002 and 2016: Insights From a Chinese Cohort.2002年至2016年期间接受治疗的缺血性中风患者的预后趋势:来自中国队列的见解。
Circ Cardiovasc Qual Outcomes. 2019 Dec;12(12):e005610. doi: 10.1161/CIRCOUTCOMES.119.005610. Epub 2019 Dec 13.
8
A systematic literature review of risk factors for stroke in China.一项针对中国脑卒中危险因素的系统文献回顾。
Cardiol Rev. 2013 Mar-Apr;21(2):77-93. doi: 10.1097/CRD.0b013e3182748d37.
9
Outline of the report on cardiovascular disease in China, 2010.中国心血管病报告 2010 概要。
Biomed Environ Sci. 2012 Jun;25(3):251-6. doi: 10.3967/0895-3988.2012.03.001.
10
Is there a stroke belt in China and why?中国有脑卒中带吗?为什么?
Stroke. 2013 Jul;44(7):1775-83. doi: 10.1161/STROKEAHA.113.001238. Epub 2013 May 14.

引用本文的文献

1
Latent profile analysis of rehabilitation motivation in Chinese patients with stroke: a cross-sectional study.中国卒中患者康复动机的潜在剖面分析:一项横断面研究。
Front Psychol. 2025 Aug 26;16:1614528. doi: 10.3389/fpsyg.2025.1614528. eCollection 2025.
2
Tea intake shows no genetic causal effect on stroke: A two-sample Mendelian randomization study based on STROBE-MR guidelines.饮茶对中风无遗传因果效应:一项基于STROBE-MR指南的两样本孟德尔随机化研究。
Medicine (Baltimore). 2025 Sep 5;104(36):e44398. doi: 10.1097/MD.0000000000044398.
3
An analysis of trends in the burden of ischemic stroke caused by air pollution in China between 1990 and 2021.
1990年至2021年间中国空气污染所致缺血性脑卒中负担的趋势分析。
BMC Public Health. 2025 Apr 28;25(1):1567. doi: 10.1186/s12889-025-22287-1.
4
Efficacy, safety, and effect on platelet activation of the timing of administration of tirofiban in patients with acute ischemic stroke.替罗非班在急性缺血性脑卒中患者中的给药时机对疗效、安全性及血小板活化的影响
Am J Transl Res. 2025 Feb 15;17(2):791-805. doi: 10.62347/JUCB8921. eCollection 2025.
5
Effects of body weight-supported Tai Chi Yunshou training on upper limb motor function in stroke patients: A three-arm parallel randomized controlled trial.体重支持下的太极云手训练对脑卒中患者上肢运动功能的影响:一项三臂平行随机对照试验。
PLoS One. 2025 Jan 9;20(1):e0314025. doi: 10.1371/journal.pone.0314025. eCollection 2025.
6
Expression profile of circular RNAs in blood samples of Northern Chinese males with intracerebral hemorrhage shows downregulation of hsa-circ-0090829.中国北方男性脑出血患者血液样本中环状RNA的表达谱显示hsa-circ-0090829表达下调。
Heliyon. 2024 Aug 8;10(16):e35864. doi: 10.1016/j.heliyon.2024.e35864. eCollection 2024 Aug 30.
7
[Virtual reality-brain computer interface hand function enhancement rehabilitation system incorporating multi-sensory stimulation].[融合多感官刺激的虚拟现实-脑机接口手部功能增强康复系统]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2024 Aug 25;41(4):656-663. doi: 10.7507/1001-5515.202312055.
8
Pterostilbene improves neurological dysfunction and neuroinflammation after ischaemic stroke via HDAC3/Nrf1-mediated microglial activation.紫檀芪通过 HDAC3/Nrf1 介导的小胶质细胞激活改善缺血性中风后的神经功能障碍和神经炎症。
Cell Mol Biol Lett. 2024 Aug 28;29(1):114. doi: 10.1186/s11658-024-00634-1.
9
Analysis of immune cells and risk factors related to lower limb deep vein thrombosis in patients with cerebral infarction.脑梗死患者下肢深静脉血栓形成相关免疫细胞及危险因素分析
Am J Clin Exp Immunol. 2024 Jun 25;13(3):133-139. doi: 10.62347/DRPN1199. eCollection 2024.
10
A deep learning algorithm to identify carotid plaques and assess their stability.一种用于识别颈动脉斑块并评估其稳定性的深度学习算法。
Front Artif Intell. 2024 Jun 17;7:1321884. doi: 10.3389/frai.2024.1321884. eCollection 2024.